Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
News by month %2 2018
News by month November 2018
PTCommunity News November 2018
FDA Will Update Its Medical Device Approval Process Following Trenchant Report
RP-L102 Offers Hope for Children With Fanconi Anemia
New Treatment for Acute Myeloid Leukemia
FDA Approves Vitrakvi for TRK Fusion Cancers
FDA Advises Caution When Selecting Pain Medicine for Intrathecal Administration
Don’t Use Sterile Drug Products From Pharm D Solutions, FDA Advises
New Indication for Promacta for Severe Aplastic Anemia
FDA Approves Gamifant for Primary Hemophagocytic Lymphohistiocytosis
New Drug Works With Other Drugs To Attack Pancreatic Cancer
Study Indicates Heart Improves with Diabetes Drug
Accipio Detects Brain Bleeds, Receives FDA 510(k) Clearance
Yupelri Approved for Chronic Obstructive Pulmonary Disease
Mushroom Extract May Eradicate Human Papilloma Virus in Women
FDA Approves Pegfilgrastim Biosimilar for Cancer
Pfizer’s Lorbrena Approved for ALK Mutation Lung Cancer
Fast-Acting Drug for Post-Partum Depression in the Works
